tiprankstipranks
Advertisement
Advertisement

CRDL Stock Latest News

Cardiol Therapeutics Details 2025 Progress and Funding for Late-Stage Cardiac Drug Programs
Company AnnouncementsCardiol Therapeutics Details 2025 Progress and Funding for Late-Stage Cardiac Drug Programs
7d ago
6K
CRDL
CRDL Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CRDL Upcoming Earnings Report: What to Expect?
10d ago
CRDL
Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference
PremiumCompany Announcements
Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference
1M ago
6K
CRDL
Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure
PremiumCompany Announcements
Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure
2M ago
6K
CRDL
Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing
PremiumCompany Announcements
Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing
2M ago
6K
CRDL
Cardiol Therapeutics Secures $13.5 Million Bought-Deal Financing to Advance Heart Disease Programs
PremiumCompany AnnouncementsCardiol Therapeutics Secures $13.5 Million Bought-Deal Financing to Advance Heart Disease Programs
2M ago
6K
CRDL
Cardiol Therapeutics Raises $14.85 Million in Bought-Deal Financing to Support Late-Stage Heart Disease Programs
Premium
Company Announcements
Cardiol Therapeutics Raises $14.85 Million in Bought-Deal Financing to Support Late-Stage Heart Disease Programs
3M ago
CRDL
Cardiol Therapeutics Secures $13.5 Million Bought Deal Financing to Advance Heart Disease Programs
Premium
Company Announcements
Cardiol Therapeutics Secures $13.5 Million Bought Deal Financing to Advance Heart Disease Programs
3M ago
CRDL
Cardiol Therapeutics trading resumes
PremiumThe Fly
Cardiol Therapeutics trading resumes
3M ago
CRDL
Cardiol Therapeutics trading halted, news pending
PremiumThe Fly
Cardiol Therapeutics trading halted, news pending
3M ago
CRDL
Cardiol Therapeutics Reaches 50% Enrollment in Pivotal Phase III MAVERIC Trial for Recurrent Pericarditis
PremiumCompany Announcements
Cardiol Therapeutics Reaches 50% Enrollment in Pivotal Phase III MAVERIC Trial for Recurrent Pericarditis
3M ago
6K
CRDL
Cardiol Therapeutics: Strong Buy Rating Backed by Promising CardiolRx Trial Results and Strategic Growth Potential
PremiumRatings
Cardiol Therapeutics: Strong Buy Rating Backed by Promising CardiolRx Trial Results and Strategic Growth Potential
4M ago
CRDL
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
PremiumTipRanks NewswireNew Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
4M ago
CRDL
Cardiol Therapeutics Reports Positive Phase II ARCHER Trial Results for CardiolRx™
Premium
Company Announcements
Cardiol Therapeutics Reports Positive Phase II ARCHER Trial Results for CardiolRx™
4M ago
6K
CRDL
Cardiol Therapeutics Reports Financial Challenges Amid Clinical Progress
Premium
Company Announcements
Cardiol Therapeutics Reports Financial Challenges Amid Clinical Progress
4M ago
CRDL
Cardiol Therapeutics: Promising Pipeline and Financial Stability Support Buy Rating
PremiumRatings
Cardiol Therapeutics: Promising Pipeline and Financial Stability Support Buy Rating
5M ago
CRDL
Cardiol Therapeutics Reports Q3 2025 Financial Results Amidst Cash Decrease
PremiumCompany Announcements
Cardiol Therapeutics Reports Q3 2025 Financial Results Amidst Cash Decrease
5M ago
6K
CRDL
Cardiol Therapeutics Secures U.S. Patent for Heart Drugs
PremiumCompany Announcements
Cardiol Therapeutics Secures U.S. Patent for Heart Drugs
5M ago
6K
CRDL
Cardiol Therapeutics to Present Promising ARCHER Trial Results at ESC Meeting
PremiumCompany Announcements
Cardiol Therapeutics to Present Promising ARCHER Trial Results at ESC Meeting
5M ago
CRDL
Cardiol Therapeutics Raises $16 Million Through Recent Securities Distribution
PremiumCompany AnnouncementsCardiol Therapeutics Raises $16 Million Through Recent Securities Distribution
5M ago
6K
CRDL
Cardiol Therapeutics’ Phase-3 Trial: A Potential Game-Changer in Recurrent Pericarditis Treatment
Premium
Company Announcements
Cardiol Therapeutics’ Phase-3 Trial: A Potential Game-Changer in Recurrent Pericarditis Treatment
5M ago
CRDL
Cardiol Therapeutics Secures $11 Million to Advance Heart Disease Therapies
Premium
Company Announcements
Cardiol Therapeutics Secures $11 Million to Advance Heart Disease Therapies
5M ago
6K
CRDL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >